Insider Transactions Reported by 20 Insiders of IGM Biosciences, Inc.

Location
Mountain View, CA

Insiders trading volume in the past year

IGM Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fred Schwarzer CEO AND PRESIDENT, Director $5,156,021 13 Sep 2024
Bruce Keyt Chief Scientific Officer $2,849,933 13 Sep 2024
Chris H. Takimoto Chief Medical Officer $1,780,795 13 Sep 2024
Daniel ShinYu Chen Chief Medical Officer $769,019 01 Jul 2021
George Gauthier Chief Commercial Officer $261,637 29 Nov 2023
MICHAEL D. LOBERG Director $230,637 29 Sep 2023
Misbah Tahir Chief Financial Officer $216,453 -$21,965 -9.2% 23 Jul 2025
Lisa Lynn Decker Chief Business Officer $86,765 -$12,302 -12.4% 23 Jul 2025
Steven Weber Principal Accounting Officer $31,814 -$6,672 -17.3% 16 Jun 2025
Redmile Group, LLC Director, 10%+ Owner $0 14 Aug 2025
Michael Lee Director $0 14 Aug 2025
Topsoe Holding A/S 10%+ Owner $0 14 Aug 2025
Mary Beth Harler Chief Executive Officer, Director $0 -$29,297 -100% 14 Aug 2025
BAKER BROS. ADVISORS LP Former 10% owner and director $0 14 Aug 2025
H.Z. Thompson Director $0 14 Aug 2025
Julie Hambleton Director $0 14 Aug 2025
William Strohl Director $0 14 Aug 2025
Christina Teng Topsoe Director, 10%+ Owner $0 14 Aug 2025
Jakob Haldor Topsoe Director, 10%+ Owner $0 14 Aug 2025
M. KATHLEEN BEHRENS Director $0 14 Aug 2025

Recent Insider Transactions by Companies or Individuals for IGM Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.